Is this you? Create Your Porfile
Avatar

Olaf Peters

Bayer HealthCare Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Olaf Peters is active.

Explore More

Publication

Featured researches published by Olaf Peters.

Archive | 2005

New 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17beta-hydroxy steroid dehydrogenase type 1

Alexander Hillisch; Olaf Peters; Christian Gege; Wilko Regenhardt; Gabriele Moeller; Dominga Deluca; Jerzy Adamski; Walter Dr Elger; Birgitt Schneider

Archive | 2008

DIAMINOPYRIMIDINES AS MODULATORS OF THE EP2 RECEPTOR

Nico Bräeuer; Bernd Buchmann; Marcus Koppitz; Antonius Ter Laak; Gernot Langer; Bernhard Lindenthal; Olaf Peters; Tim Wintermantel

Archive | 2013

Novel benzimidazole derivatives as ep4 antagonists

Olaf Peters; Nico Bräuer; Thorsten Blume; Laak Antonius Ter; Ludwig Zorn; Jens Nagel; Stefan Kaulfuss; Gernot Langer; Joachim Kuhnke

Archive | 2005

NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1

Alexander Hillisch; Wilko Regenhardt; Christian Gege; Olaf Peters; Ulrich Bothe; Jerzy Adamski; Gabriele Moeller; Andrea Rosinus; Walter Dr Elger; Birgitt Schneider

Archive | 2008

5,6 substituted benzamide derivatives as modulators of EP2 receptors

Bernd Buchmann; Nico Bräuer; Marcus Koppitz; Olaf Peters; Antonius Ter Laak; Bernhard Lindenthal; Gernot Langer; Tim Wintermantel

Archive | 2008

Benzocycloheptene derivatives as estrogens having selective activity

Ralf Wyrwa; Olaf Peters; Rolf Bohlmann; Peter Droescher; Katja Prelle; Karl Heinrich Fritzemeier; Hans Peter Muhn

Archive | 2008

N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors

Bernd Buchmann; Nico Bräuer; Marcus Koppitz; Olaf Peters; Antonius Ter Laak; Bernhard Lindenthal; Gernot Langer; Tim Wintermantel

Archive | 2006

N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators

Nico Bräuer; Bernd Buchmann; Marcus Koppitz; Laak Antonius Ter; Gernot Langer; Bernhard Lindenthal; Olaf Peters; Tim Wintermantel

Archive | 2016

Novel benzimidazole derivatives as EP4 ligands

Olaf Peters; Nico Bräuer; Ulrich Bothe; Marcus Koppitz; Jens Nagel; Gernot Langef

Archive | 2008

2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Alexander Hillisch; Olaf Peters; Christian Gege; Wilko Regenhardt; Gabriele Moeller; Dominga Deluca; Jerzy Adamski; Walter Dr Elger; Birgitt Schneider

Explore More

Collaboration

Dive into the Olaf Peters's collaboration.

Top Co-Authors
Avatar

Gernot Langer

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Marcus Koppitz

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Bernd Buchmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Bernhard Lindenthal

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Nico Bräuer

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Tim Wintermantel

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Alexander Hillisch

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Antonius Ter Laak

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Walter Dr Elger

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Birgitt Schneider

Bayer HealthCare Pharmaceuticals

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge